Cargando...
What can we learn from drug marketing efficiency?
The time it takes new drugs to penetrate the market is shrinking. David Kao suggests how drug companies’ techniques could be used to improve safety surveillance systems
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group Ltd.
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3230247/ https://ncbi.nlm.nih.gov/pubmed/19050331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.a2591 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|